Hydroxychloroquine does not reduce the risk of death

                   Many people are taking hydroxychloroquine for the treatment of coronavirus. Many became quite optimistic about it. Some countries have also allowed the use of this drug in the treatment of corona.But a large study and clinical trial in the UK on Friday revealed that there was no benefit in taking this drug to treat coronary malaria. It is also a bit toxic. Therefore, the researchers said that the application and trial of this drug should be stopped now. News from AFP.

"We want to conclude that hydroxychloroquine does not reduce the risk of death in hospitalized patients," said Martin Laundry, a professor and co-researcher at Oxford University. It's not just in the UK, it's in many countries that should be stopped. "

11,000 patients from 185 hospitals in the United Kingdom were selected for the study. Of these, 1,542 were given medical services as well as hydroxychloroquine. Besides, medical services were provided separately to 3,132 people. But no significant difference was found in the mortality rate. The study also found no evidence that the use of this malaria drug reduced patients' time in the hospital.


"It's a very important result," said Peter Open's Professor at Imperial College London. Through this we have found clear evidence that hydroxychloroquine has no effect on hospitalized patients. There is no benefit in applying it to the treatment of corona. In fact, this drug is also toxic. So its trial and application should be stopped now. '

The United States recently sent 2 million doses of hydroxychloroquine to Brazil to fight corona. The country's President Donald Trump has been taking the drug for more than a week and a half to survive Corona. India has also allowed the use of this drug in the treatment of hospitalized patients.